Nordic Bioscience landing a multi-million deal with Danish pharmaceutical
A multi-million deal in Denmark
Nordic Bioscience has established yet another collaboration with a large Danish pharmaceutical company. In the context of this multi-million deal, we provide clinical laboratory services for safety testing requiring exceptional speed, flexibility, and customized electronic data delivery.
Safety studies are simply unavoidable before a drug candidate can be rolled out on the market. At the same time, Nordic Bioscience is the only CAP-certified lab in Scandinavia that can assist in regulatory decision-making by assessing the safety and benefit-risk profile of a drug. Our laboratory provides full central laboratory services for clinical development.
If you would like to know more about our central laboratory and safety testing capabilities, please visit our website on the link below and get in touch with us.
